Biomarkers of Parkinson's disease: Striatal sub-regional structural morphometry and diffusion MRI

Neuroimage Clin. 2019;21:101597. doi: 10.1016/j.nicl.2018.11.007. Epub 2018 Nov 16.

Abstract

Parkinson's disease (PD) is a progressive neurological disorder that has no reliable biomarkers. The aim of this study was to explore the potential of semi-automated sub-regional analysis of the striatum with magnetic resonance imaging (MRI) to distinguish PD patients from controls (i.e., as a diagnostic biomarker) and to compare PD patients at different stages of disease. With 3 Tesla MRI, diffusion- and T1-weighted scans were obtained on two occasions in 24 PD patients and 18 age-matched, healthy controls. PD patients completed one session on and the other session off dopaminergic medication. The striatum was parcellated into seven functionally disparate sub-regions. The segmentation was guided by reciprocal connections to distinct cortical regions. Volume, surface-based morphometry, and integrity of white matter connections were calculated for each striatal sub-region. Test-retest reliability of our volume, morphometry, and white matter integrity measures across scans was high, with correlations ranging from r = 0.452, p < 0.05 and r = 0.985, p < 0.001. Global measures of striatum such as total striatum, nucleus accumbens, caudate nuclei, and putamen were not significantly different between PD patients and controls, indicating poor sensitivity of these measures, which average across sub-regions that are functionally heterogeneous and differentially affected by PD, to act as diagnostic biomarkers. Further, these measures did not correlate significantly with disease severity, challenging their potential to serve as progression biomarkers. In contrast, a) decreased volume and b) inward surface displacement of caudal-motor striatumthe region first and most dopamine depleted in PDdistinguished PD patients from controls. Integrity of white matter cortico-striatal connections in caudal-motor and adjacent striatal sub-regions (i.e., executive and temporal striatum) was reduced for PD patients relative to controls. Finally, volume of limbic striatum, the only striatal sub-region innervated by the later-degenerating ventral tegmental area in PD, was reduced in later-stage compared to early stage PD patients a potential progression biomarker. Segmenting striatum based on distinct cortical connectivity provided highly sensitive MRI measures for diagnosing and staging PD.

Keywords: Biomarker; Diffusion MRI; Morphometry; Parkinson's disease; Segmentation; Striatum.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Caudate Nucleus / pathology*
  • Corpus Striatum / pathology*
  • Diffusion Magnetic Resonance Imaging* / methods
  • Female
  • Gray Matter / pathology
  • Humans
  • Image Processing, Computer-Assisted / methods
  • Male
  • Parkinson Disease / complications
  • Parkinson Disease / pathology*
  • Reproducibility of Results
  • White Matter / pathology*